BiotechTube

Pneumococcal Vaccine

ApprovedRecruiting
0 views this week 0 watching⚡ Active
Interest: 50/100
50
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Vaccine

Conditions

Vaccine, Pneumococcal Disease

Trial Timeline

Mar 1, 2026 → Aug 1, 2027

NCT ID
NCT07135453

About Pneumococcal Vaccine

Pneumococcal Vaccine is a approved stage product being developed by Merck for Vaccine. The current trial status is recruiting. This product is registered under clinical trial identifier NCT07135453. Target conditions include Vaccine, Pneumococcal Disease.

What happened to similar drugs?

7 of 20 similar drugs in Vaccine were approved

Approved (7) Terminated (0) Active (13)
✅Vaxelis™MerckApproved
✅21-valent pneumococcal conjugate vaccineMerckApproved
🔄9-valent human papillomavirus vaccine (Gardasil 9) - 3 doses + 9-valent human papillomavirus vaccine (Gardasil 9) - 2 doses + 9-valent human papillomavirus vaccine (Gardasil 9) - 1 doseMerckPhase 3
✅Gardasil-9MerckApproved
🔄Rotarix + RotaTeqMerckPhase 3
✅Human papillomavirus 9-valent vaccine, recombinant + human papillomavirus vaccine, recombinantMerckApproved
🔄Seasonal Influenza VaccineNovartisPhase 3

Hype Score Breakdown

Clinical
20
Activity
15
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT07135453ApprovedRecruiting

Competing Products

20 competing products in Vaccine

See all competitors
ProductCompanyStageHype Score
AZD1222AstraZenecaPre-clinical
26
Vaxelis™MerckApproved
43
21-valent pneumococcal conjugate vaccineMerckApproved
50
Quadrivalent HPV [Type 6, 11, 16 and 18] L1 Virus-Like Particle VaccineMerckPre-clinical
26
quadrivalent human papillomavirus vaccine + quadrivalent human papillomavirus vaccineMerckPre-clinical
26
Tetanus & Diphtheria booster vaccine (Td) + TwinrixTM [Hepatitis A Inactivated & Hepatitis B (Recombinant) Vaccine] + Dukoral® Traveler's Diarrhea Vaccine (WC/rBS)MerckPre-clinical
26
9-valent human papillomavirus vaccine (Gardasil 9) - 3 doses + 9-valent human papillomavirus vaccine (Gardasil 9) - 2 doses + 9-valent human papillomavirus vaccine (Gardasil 9) - 1 doseMerckPhase 3
36
Gardasil-9MerckApproved
39
Rotarix + RotaTeqMerckPhase 3
40
Human papillomavirus 9-valent vaccine, recombinant + human papillomavirus vaccine, recombinantMerckApproved
50
Seasonal Influenza VaccineNovartisPhase 3
40
Fluad + SalineNovartisApproved
43
Monovalent inactivated influenza vaccineNovartisPhase 2
35
cTIVNovartisPhase 3
40
Monovalent inactivated influenza vaccineNovartisPhase 3
40
Fluad H5N1 Pandemic Influenza VaccineNovartisPhase 2
35
13-valent pneumococcal conjugate vaccine + 7-valent pneumococcal conjugate vaccinePfizerPhase 3
40
13-valent pneumococcal conjugate vaccine + 13-valent pneumococcal conjugate vaccinePfizerPhase 3
40
13vPnC + 23vPSPfizerPhase 3
40
13-valent pneumococcal conjugate vaccine + 13-valent pneumococcal conjugate vaccinePfizerApproved
43